Canada adult-use cannabis business-to-business net revenue up 9% year-over-year; Canada medical cannabis net revenue up 11% year-over-year
Focused execution drove sustained margin improvement with second quarter of consolidated gross margins exceeding 30%
Canopy USA strategy moving forward; special shareholder meeting scheduled for April 12, 2024
SMITHS FALLS, ON, Feb. 9, 2024 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announces its financial results for the third quarter ended December 31, 2023. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
Highlights
- Achieved consolidated gross margins of 36% in Q3 FY2024, with Canada cannabis gross margins increasing to 28% in Q3 FY2024, up from (11)% in Q3 FY2023.
- Excluding the impact of the divestiture of the Canada national retail business in Q3 FY2023, Q3 FY2024…
